Andrea Johnston Joins Truckstop as Chief Revenue Officer
With over 30 years of international experience in B2B sales, customer success, and business development, Johnston brings a wealth of expertise to Truckstop. Most recently, she served as the Chief Revenue Officer at Alludo (formerly known as Corel), and prior to that, she held the position of Chief Operating Officer at OpenTable.
"I am thrilled to join the Truckstop team to help provide excellent solutions and services to carriers, brokers, and shippers," said Johnston. "In many ways, our mission is similar to several of the companies that I have worked for over my career, and I am passionate about empowering our customers to become even more successful."
"Andrea's wealth of experience as a sales and operations leader, coupled with her impressive history as a revenue strategist at multiple SaaS companies, makes her the ideal executive for this position," said
Additionally, Johnston serves as an advisor to several tech startups, assisting them in activating their go-to-market plans.
About Truckstop
Truckstop is a trusted partner for carriers, brokers, and shippers, empowering the freight community through a platform of innovative solutions for the entire freight lifecycle to increase efficiency, automate processes, and accelerate growth. As one of the industry's largest neutral freight marketplaces, Truckstop provides the customer service as well as scale of quality loads and trucks to give customers of all sizes, whether on the road or in the office, the transparency and freedom to build lasting relationships and grow their businesses. To learn how Truckstop is helping move the freight community forward, visit https://truckstop.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/andrea-johnston-joins-truckstop-as-chief-revenue-officer-302144904.html
SOURCE Internet Truckstop Group, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- What To Expect After Your Doctor Finds a Lung Nodule
- Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC
- 10 Years of the Elbphilharmonie Hamburg: Spectacular Concert Hall Celebrates Its Success Story
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share